Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines

Mirosława Koronkiewicz, Andrzej Orzeszko|BMC Cancer|2022

Cited by 8